Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Novo Nordisk’s hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Tirzepatide has been shown to help people lose more weight compared to semaglutide at the dosage regimens currently available ...

Still, companies that sell compounded weight loss drugs have vowed to continue to ... tool isn’t benefitting anybody.” Wegovy and Zepbound have been approved by the FDA as a weight loss ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

The future of American drug innovation is threatened by U.S. regulations that permit knockoff versions of new drugs to be ...

The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

But there are many questions left to answer, not least what the future holds for weight-loss medications and society at large ...

The exorbitant costs of drugs like Wegovy — especially compared to other countries — have prompted some insurers to tighten ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...